News in brief

Lallemand partners with Aventus for delivery technology agreement

By Stephen Daniells contact

- Last updated on GMT

Lallemand partners with Aventus for delivery technology agreement

Related tags: Probiotics, delivery systems

Canada’s Lallemand Health Solutions has signed an exclusive global agreement for Aventus’ NutraJIT oral delivery technology.

NutraJIT stands for ‘nutraceuticals delivered just in time’ is an all-natural delivery technology that reportedly offers formulators a range of benefits, including protection against stomach acids, the reduction of side effects, and time-release capabilities, to existing and future products.

The technology was initially developed for the probiotic market, it can also be used for other active ingredients, such as vitamins, minerals, herbal extracts, and specialty supplements.

“NutraJIT is a derivative of food-product protein and, as such, ticks all the boxes for consumers: all-natural, allergen-free, clean label and added protection,” ​explained Bérengère Feuz, Marketing Director at Lallemand Health Solutions.

“Even though we have existing protective technologies to make sure all our probiotic strains reach their site of action, NutraJIT brings its own additional benefits for consumers. Basically, the ingredient creates a gel barrier in a low pH environment, protecting the probiotic formula from stomach acidity. When reaching the intestines, it will desegregate as the pH is increasing, releasing the bacteria where they need to be. We are eager to bring this new attractive solution to the probiotic market and are actively preparing the launch for the coming fall.”

Marie-Eve Boyte, Scientific Affairs Director at Lallemand Health Solutions, added: “This protective technology is efficient on both capsules and tablets, which is a great addition to our existing portfolio. NutraJIT is a versatile vehicle for active ingredients to make their way to their site of action, without being affected by the stomach fluids acidity and with reduced gastric side effects.”

Nicolas Kronström, COO at Aventus Innovations, said: “As a young innovative Canadian company which develops oral delivery technologies intended for use by dietary supplements companies like Lallemand Health Solutions, we are thrilled to have concluded this agreement which will allow our ingredients to serve consumers, worldwide.”



Related news

Related products

show more

SEBiotic™ GRAS Press Release

SEBiotic™ GRAS Press Release

Specialty Enzymes & Probiotics | 06-Jul-2021 | Press Release

Specialty Enzymes & Probiotics is proud to announce our powerful, research-backed probiotic SEBiotic™ (Bacillus coagulans LBSC) received a No Objections...



Specialty Enzymes & Probiotics | 06-Jul-2021 | Product Brochure

SEBiotic™ (Bacillus coagulans LBSC) is a powerful spore-forming, shelf-stable probiotic. Studies show SEBiotic™ promotes microflora balance, supports immunomodulation...

Related suppliers

Follow us


View more